Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $(0.00) by Infinity percent. This is a 24.14 percent increase over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $256.147 million which beat the analyst consensus estimate of $219.988 million by 16.44 percent. This is a 31.74 percent increase over sales of $194.430 million the same period last year.